Used in pharmaceutical research as a potent and selective inhibitor of certain kinases involved in inflammatory and oncogenic signaling pathways. Shows promise in the development of targeted therapies for autoimmune diseases and specific cancer types due to its ability to modulate key cellular processes such as proliferation and immune response. Its structure allows for high binding affinity and improved metabolic stability, making it suitable for oral administration in preclinical models. Currently investigated for optimization of pharmacokinetic properties and safety profile in drug discovery programs.